M3. Cardiovascular outcome of SGLT-2 Inhibitor in patient with Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Control Trial

M3. Cardiovascular outcome of SGLT-2 Inhibitor in patient with Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Control Trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal supplements 2021-11, Vol.23 (Supplement_F)
Hauptverfasser: Mukhammad, W W, Kembangsari, C, Santoso, Y A A J, Mukti, I R, Putra, H B P, Adiwinoto, R P, Adiwinoto, R D
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_F
container_start_page
container_title European heart journal supplements
container_volume 23
creator Mukhammad, W W
Kembangsari, C
Santoso, Y A A J
Mukti, I R
Putra, H B P
Adiwinoto, R P
Adiwinoto, R D
description
doi_str_mv 10.1093/eurheartjsupp/suab123.002
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_eurheartjsupp_suab123_002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_eurheartjsupp_suab123_002</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1093_eurheartjsupp_suab123_0023</originalsourceid><addsrcrecordid>eNqlj8tKxDAYhYMoOF7e4fcB2knSqc64k6qj4Gy0C3fhb5vSDGlSclHqShB8UJ_EKczGtavzLc458BFywWjK6Cqby-g6iS5sfRyGuY9YMZ6llPIDMmN5vkj4kuWHE3OaXF3mr8fkxPvtrpAtF3RGvjdZ-vP5VaBrlH1DX0eNDmwMte0l2BZe1k9lwuHRdKpSwTpQBgYMSpoA7yp0UI6DBA63CisZpIeN1FqF6K8BdxwwuTGoR6_89PaMprG9-pANFNYEZzWUTqE-I0ctai_P93lKVvd3ZfGQ1M5672QrBqd6dKNgVEzi4o-42IuLyes_21-1pm7v</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>M3. Cardiovascular outcome of SGLT-2 Inhibitor in patient with Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Control Trial</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Mukhammad, W W ; Kembangsari, C ; Santoso, Y A A J ; Mukti, I R ; Putra, H B P ; Adiwinoto, R P ; Adiwinoto, R D</creator><creatorcontrib>Mukhammad, W W ; Kembangsari, C ; Santoso, Y A A J ; Mukti, I R ; Putra, H B P ; Adiwinoto, R P ; Adiwinoto, R D</creatorcontrib><identifier>ISSN: 1520-765X</identifier><identifier>EISSN: 1554-2815</identifier><identifier>DOI: 10.1093/eurheartjsupp/suab123.002</identifier><language>eng</language><ispartof>European heart journal supplements, 2021-11, Vol.23 (Supplement_F)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Mukhammad, W W</creatorcontrib><creatorcontrib>Kembangsari, C</creatorcontrib><creatorcontrib>Santoso, Y A A J</creatorcontrib><creatorcontrib>Mukti, I R</creatorcontrib><creatorcontrib>Putra, H B P</creatorcontrib><creatorcontrib>Adiwinoto, R P</creatorcontrib><creatorcontrib>Adiwinoto, R D</creatorcontrib><title>M3. Cardiovascular outcome of SGLT-2 Inhibitor in patient with Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Control Trial</title><title>European heart journal supplements</title><issn>1520-765X</issn><issn>1554-2815</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqlj8tKxDAYhYMoOF7e4fcB2knSqc64k6qj4Gy0C3fhb5vSDGlSclHqShB8UJ_EKczGtavzLc458BFywWjK6Cqby-g6iS5sfRyGuY9YMZ6llPIDMmN5vkj4kuWHE3OaXF3mr8fkxPvtrpAtF3RGvjdZ-vP5VaBrlH1DX0eNDmwMte0l2BZe1k9lwuHRdKpSwTpQBgYMSpoA7yp0UI6DBA63CisZpIeN1FqF6K8BdxwwuTGoR6_89PaMprG9-pANFNYEZzWUTqE-I0ctai_P93lKVvd3ZfGQ1M5672QrBqd6dKNgVEzi4o-42IuLyes_21-1pm7v</recordid><startdate>20211121</startdate><enddate>20211121</enddate><creator>Mukhammad, W W</creator><creator>Kembangsari, C</creator><creator>Santoso, Y A A J</creator><creator>Mukti, I R</creator><creator>Putra, H B P</creator><creator>Adiwinoto, R P</creator><creator>Adiwinoto, R D</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20211121</creationdate><title>M3. Cardiovascular outcome of SGLT-2 Inhibitor in patient with Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Control Trial</title><author>Mukhammad, W W ; Kembangsari, C ; Santoso, Y A A J ; Mukti, I R ; Putra, H B P ; Adiwinoto, R P ; Adiwinoto, R D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1093_eurheartjsupp_suab123_0023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mukhammad, W W</creatorcontrib><creatorcontrib>Kembangsari, C</creatorcontrib><creatorcontrib>Santoso, Y A A J</creatorcontrib><creatorcontrib>Mukti, I R</creatorcontrib><creatorcontrib>Putra, H B P</creatorcontrib><creatorcontrib>Adiwinoto, R P</creatorcontrib><creatorcontrib>Adiwinoto, R D</creatorcontrib><collection>CrossRef</collection><jtitle>European heart journal supplements</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mukhammad, W W</au><au>Kembangsari, C</au><au>Santoso, Y A A J</au><au>Mukti, I R</au><au>Putra, H B P</au><au>Adiwinoto, R P</au><au>Adiwinoto, R D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>M3. Cardiovascular outcome of SGLT-2 Inhibitor in patient with Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Control Trial</atitle><jtitle>European heart journal supplements</jtitle><date>2021-11-21</date><risdate>2021</risdate><volume>23</volume><issue>Supplement_F</issue><issn>1520-765X</issn><eissn>1554-2815</eissn><doi>10.1093/eurheartjsupp/suab123.002</doi></addata></record>
fulltext fulltext
identifier ISSN: 1520-765X
ispartof European heart journal supplements, 2021-11, Vol.23 (Supplement_F)
issn 1520-765X
1554-2815
language eng
recordid cdi_crossref_primary_10_1093_eurheartjsupp_suab123_002
source Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title M3. Cardiovascular outcome of SGLT-2 Inhibitor in patient with Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Control Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T19%3A37%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=M3.%E2%80%83Cardiovascular%20outcome%20of%20SGLT-2%20Inhibitor%20in%20patient%20with%20Type%202%20Diabetes%20Mellitus:%20a%20Meta-Analysis%20of%20Randomized%20Control%20Trial&rft.jtitle=European%20heart%20journal%20supplements&rft.au=Mukhammad,%20W%20W&rft.date=2021-11-21&rft.volume=23&rft.issue=Supplement_F&rft.issn=1520-765X&rft.eissn=1554-2815&rft_id=info:doi/10.1093/eurheartjsupp/suab123.002&rft_dat=%3Ccrossref%3E10_1093_eurheartjsupp_suab123_002%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true